Researchers Propose Gene-Edited Canine Models to Study Autism Spectrum Disorder

Researchers are proposing the use of gene-edited canine models to study autism spectrum disorder (ASD) as a potential solution to the historical difficulty of translating pharmacological treatments from experimental models to human patients. A peer-reviewed perspective published in the journal *Genomic Psychiatry* suggests that domestic dogs may provide a more effective biological bridge for testing new therapies than traditional laboratory models.

The study highlights that past efforts to develop drug treatments for ASD have frequently stalled when moving from animal testing to human clinical trials. By utilizing gene-editing technology to create canine models that mirror the genetic markers associated with autism in humans, scientists aim to improve the accuracy of preclinical research. The authors of the report argue that because dogs share similar social behaviors and environmental exposures with humans, they offer a unique opportunity to observe how potential treatments affect complex neurological conditions. This approach seeks to address the current limitations in drug development by providing a more reliable framework for evaluating the safety and efficacy of new interventions before they reach human subjects.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 24, 2026

Author

GOAI